OSUR

Peers: QDEL TRIB BDX ABT CODX BMRA DHR BIO DGX BJDX

| Held by: VTI IWM VXF DFSV IWN DFAS VTWO SCHA DFAC DFMC

Index	RUT
Market Cap	283.83M
Enterprise Value	140.58M
Income	-49.13M
Sales	112.41M
Book/sh	4.61
Cash/sh	2.33
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	501
IPO	Nov 17, 1986

P/E	-
Forward P/E	-
PEG	-
P/S	2.52
P/B	0.89
P/C	1.77
P/FCF	-
EV/EBITDA	-
EV/Sales	1.25
Quick Ratio	7.68
Current Ratio	8.88
Debt/Eq	0.05
LT Debt/Eq	0.05
Option/Short	Yes / Yes

EPS (ttm)	-0.69
EPS next Y	-0.62
EPS next Q	-0.20
EPS this Y	35.64%
EPS next Y	-2.48%
EPS next 5Y	21.77%
EPS past 3/5Y	-58.18% -33.45%
Sales past 3/5Y	-33.29% -7.70%
EPS Y/Y TTM	-0.63%
Sales Y/Y TTM	-18.86%
EPS Q/Q	133.72%
Sales Q/Q	-1.93%
Earnings	Nov 09 AMC
EPS/Sales Surpr.	133.33% 5.29%

Insider Own	6.61%
Insider Trans	1.67%
Inst Own	85.68%
Inst Trans	-1.99%
ROA	-12.20%
ROE	-14.07%
ROIC	-14.75%
Gross Margin	38.89%
Oper. Margin	-64.85%
Profit Margin	-43.70%
SMA20	5.97%
SMA50	9.93%
SMA200	17.56%
Trades

Shs Outstand	68.97M
Shs Float	64.41M
Short Float	4.24%
Short Ratio	5.16
Short Interest	2.73M
52W High	4.58 -10.14%
52W Low	2.08 97.86%
Volatility	6.04% 4.74%
ATR (14)	0.19
RSI (14)	59.85
Beta	1.08
Rel Volume	1.28
Avg Volume	528.82K
Volume	392,149

Perf Week	6.62%
Perf Month	7.73%
Perf Quarter	3.66%
Perf Half Y	39.03%
Perf YTD	70.06%
Perf Year	43.39%
Perf 3Y	-20.24%
Perf 5Y	-61.43%
Perf 10Y	-45.13%
Recom	2.00
Target Price	5.50
Prev Close	4.16
Price	4.12
Change %	-1.07%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-03-23	Resumed	Evercore ISI	In-line	$5
Sep-22-21	Downgrade	Raymond James	Outperform → Mkt Perform
Aug-21-20	Initiated	Evercore ISI	Outperform	$22
Aug-10-20	Initiated	JP Morgan	Neutral	$18
Aug-10-20	Initiated	Citigroup	Buy	$18
Aug-07-20	Upgrade	Raymond James	Mkt Perform → Outperform	$16
Jun-25-20	Initiated	Lake Street	Buy	$19
Apr-21-20	Resumed	Stephens	Equal-Weight	$14
Oct-23-18	Resumed	Raymond James	Mkt Perform
Jul-16-18	Downgrade	Stephens	Overweight → Equal-Weight
Nov-02-17	Downgrade	Jefferies	Buy → Hold
Feb-09-17	Upgrade	Raymond James	Mkt Perform → Outperform
Jun-13-16	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-05-15	Reiterated	Mizuho	Buy	$12 → $8
May-07-15	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jan-23-15	Reiterated	Mizuho	Buy	$10 → $12
Jun-12-14	Reiterated	Canaccord Genuity	Buy	$10 → $11
Jun-11-14	Reiterated	Mizuho	Buy	$9 → $10
Dec-21-12	Initiated	Mizuho	Buy	$9
Aug-08-12	Upgrade	Barrington Research	Mkt Perform → Outperform	$12.50

Show Previous Ratings

Oct-26-26 04:05PM	OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th (GlobeNewswire)
Aug-06-26 01:04AM	OraSure Technologies Inc (OSUR) (Q2 2026) Earnings Call Highlights: Revenue Surges 9. ... (GuruFocus.com)
Aug-05-26 05:53PM	OraSure: Q2 Earnings Snapshot (Associated Press)
04:05PM	OraSure Announces Second Quarter 2026 Financial Results (GlobeNewswire)
Jul-22-26 04:10PM	OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th (GlobeNewswire) +6.33%
04:30PM	Loading…
Jul-21-26 04:30PM	OraSure Receives Emergency Use Authorization for Second Generation Ebola Test (GlobeNewswire)
Jun-11-26 08:00AM	OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient-Friendly Access to Testing for Sexually Transmitted Infections (GlobeNewswire)
May-06-26 05:33PM	OraSure: Q1 Earnings Snapshot (Associated Press)
04:05PM	OraSure Announces First Quarter 2026 Financial Results (GlobeNewswire)
Apr-22-26 04:10PM	OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th (GlobeNewswire)
Apr-16-26 08:10PM	OraSure Technologies Appoints John D. Bertrand to its Board of Directors (GlobeNewswire)
Mar-17-26 04:52PM	OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital (GlobeNewswire)
09:15AM	Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance (Business Wire)
Feb-26-26 02:11AM	OraSure Technologies Q4 Earnings Call Highlights (MarketBeat) +10.00%
12:02AM	OraSure Technologies Inc (OSUR) Q4 2025 Earnings Call Highlights: Revenue Exceeds Expectations ... (GuruFocus.com)
05:39PM	Loading…
Feb-25-26 05:39PM	OraSure: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	OraSure Announces Fourth Quarter 2025 Financial Results (GlobeNewswire)
Feb-24-26 08:15AM	InfuSystems Holdings, Inc. (INFU) Q4 Earnings Beat Estimates (Zacks)
Feb-10-26 08:05AM	OraSure to Launch OraQuick HIV Self-Test in Canada (GlobeNewswire)
Feb-09-26 04:15PM	OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th (GlobeNewswire)
Feb-04-26 06:15PM	Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates (Zacks) -5.86%
Jan-15-26 01:00PM	OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital (GlobeNewswire)
08:30AM	Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors (Business Wire)
Jan-06-26 11:39AM	OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device (Zacks)
Jan-05-26 08:00AM	OraSure Submits CT/NG Molecular Self-Test and Colli-Pee Urine Collection Device for FDA Review (GlobeNewswire)
Dec-17-25 01:23PM	OraSure Technologies Issues Statement Regarding Altai Capital's Intent to Nominate Director Candidates (GlobeNewswire)
08:00AM	Altai Capital Management Announces Intention to Nominate Two Highly-Qualified Candidates for Election to OraSure Board of Directors (Business Wire)
Nov-17-25 07:45AM	OraSure to Participate in Upcoming Investor Conference (GlobeNewswire)
Nov-06-25 12:07AM	OraSure Technologies Inc (OSUR) Q3 2025 Earnings Call Highlights: Navigating Market Challenges ... (GuruFocus.com) -6.61%
Nov-05-25 06:50PM	OraSure Technologies (OSUR) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
05:49PM	Loading…
05:49PM	OraSure: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	OraSure Announces Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 08:41AM	OraSure Technologies Inc (OSUR) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
07:50AM	InfuSystems Holdings, Inc. (INFU) Tops Q3 Earnings Estimates (Zacks)
Oct-29-25 07:30AM	OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th (GlobeNewswire)
Oct-28-25 04:22PM	OraSure Technologies Appoints Steven K. Boyd to its Board of Directors (GlobeNewswire)
Oct-09-25 08:10AM	Tilray Brands, Inc. (TLRY) Reports Break-Even Earnings for Q1 (Zacks)
Sep-12-25 06:59PM	OraSure, Central Pacific, and More Stocks See Action From Activist Investors (Barrons.com)
Sep-09-25 06:19AM	Exclusive-Altai Capital lays groundwork for board fight at OraSure Technologies, sources say (Reuters)
Aug-06-25 03:28AM	OraSure Technologies Inc (OSUR) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) -8.49%
Aug-05-25 06:30PM	OraSure Technologies (OSUR) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
05:25PM	OraSure: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	OraSure Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-04-25 10:07AM	Earnings To Watch: OraSure Technologies Inc (OSUR) Reports Q2 2025 Result (GuruFocus.com)
07:05AM	OraSure Appoints Anne Messing as Chief Commercial Officer (GlobeNewswire)
Jul-21-25 04:05PM	OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th (GlobeNewswire) +6.15%
Jul-14-25 12:03PM	OraSure Technologies received takeover bid from industry entrepreneur, sources say (Reuters)
Jul-10-25 07:05AM	OraSure Launches Novel Blood Collection Device for Proteomic Research (GlobeNewswire)
May-20-25 11:35AM	Evercore says 23andMe buyout removes downside case for OraSure (TipRanks) +6.46%
May-14-25 08:00AM	Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing (GlobeNewswire) -6.04%
May-08-25 09:50AM	Q1 2025 OraSure Technologies Inc Earnings Call (Thomson Reuters StreetEvents) -6.81%
03:33AM	OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
May-07-25 08:02PM	Orasure technologies outlines Q2 2025 revenue guidance of $28.5M-$32.5M amid new product launches and customer expansions (Seeking Alpha)
08:01PM	OraSure Technologies, Inc. (OSUR) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:55PM	OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:47PM	OraSure: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	OraSure Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-01-25 05:45PM	Envista (NVST) Beats Q1 Earnings and Revenue Estimates (Zacks)
Apr-30-25 03:47PM	OraSure Technologies: Historically Cheap (Seeking Alpha)
Apr-23-25 04:05PM	OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th (GlobeNewswire)
07:40AM	Boston Scientific (BSX) Q1 Earnings and Revenues Top Estimates (Zacks)
Apr-10-25 11:35AM	GE HealthCare (GEHC) Surges 10.6%: Is This an Indication of Further Gains? (Zacks) -6.96%
Apr-02-25 03:35PM	OraSure Technologies, Inc. (OSUR): Insider Were Buying In Q1 2025 (Insider Monkey)
Mar-24-25 07:30AM	OraSure Announces $40 Million Stock Repurchase Program (GlobeNewswire) +6.40%
Feb-26-25 09:03AM	Q4 2024 OraSure Technologies Inc Earnings Call (Thomson Reuters StreetEvents) -23.50%
02:16AM	OraSure Technologies Inc (OSUR) Q4 2024 Earnings Call Highlights: Strong Core Revenue Growth ... (GuruFocus.com)
Feb-25-25 06:10PM	OraSure Technologies (OSUR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:15PM	OraSure: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	OraSure Reports Fourth Quarter 2024 Financial Results (GlobeNewswire)
01:50AM	OraSure Technologies Inc (OSUR) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-14-25 08:45AM	OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th (GlobeNewswire)
Jan-27-25 12:00PM	OraSure (OSUR) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
Jan-23-25 09:40AM	Should Value Investors Buy OraSure Technologies (OSUR) Stock? (Zacks)
Jan-07-25 04:05PM	OraSure to Present at the J.P Morgan Healthcare Conference (GlobeNewswire)
09:40AM	Are Investors Undervaluing OraSure Technologies (OSUR) Right Now? (Zacks)
08:50AM	CORRECTION - OraQuick HIV Self-Test Now Approved for Use in Adolescents (GlobeNewswire)
07:05AM	OraQuick HIV Self-Test Now Approved for Use in Adolescents (GlobeNewswire)
Dec-19-24 04:02PM	OraSure Technologies Acquires Sherlock Biosciences (GlobeNewswire)
Dec-02-24 07:05AM	OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test (GlobeNewswire)
Nov-28-24 09:40AM	Is OraSure Technologies (OSUR) Stock Undervalued Right Now? (Zacks)
Nov-18-24 04:05PM	OraSure to Participate in Upcoming Investor Conference (GlobeNewswire)
Nov-12-24 09:40AM	Is OraSure Technologies (OSUR) a Great Value Stock Right Now? (Zacks)
Nov-07-24 10:00AM	OraSure Technologies Inc (OSUR) Q3 2024 Earnings Call Highlights: Revenue Growth in Diagnostics ... (GuruFocus.com)
Nov-06-24 05:55PM	OraSure Technologies (OSUR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:58PM	OraSure: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	OraSure Reports Q3 '24 Revenue of $39.9 Million (GlobeNewswire)
Nov-05-24 08:01AM	OraSure Technologies Inc (OSUR) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-22-24 04:05PM	OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th (GlobeNewswire)
Oct-13-24 02:11PM	OraSure Technologies Inc. (OSUR): Among the Most Profitable Penny Stocks to Invest In (Insider Monkey)
Oct-04-24 05:03PM	Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc (GuruFocus.com)
Sep-12-24 01:25AM	BlackRock Inc. Increases Stake in OraSure Technologies Inc. (GuruFocus.com)
Sep-09-24 07:05AM	OraSure Technologies Elects Jack Kenny to the Board of Directors (GlobeNewswire)
Aug-07-24 10:16AM	Q2 2024 OraSure Technologies Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-06-24 06:25PM	OraSure Technologies (OSUR) Tops Q2 Earnings and Revenue Estimates (Zacks)
05:20PM	OraSure: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	OraSure Reports Q2 24 Revenue of $54.3 Million (GlobeNewswire)
Jul-22-24 04:05PM	OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th (GlobeNewswire)
Jun-27-24 07:05AM	OraSure Technologies Supports National HIV Testing Day (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Boyd Steven Kyle	Director	May 13 '26	Buy	3.02	25,000	75,500	88,462	May 14 08:55 PM
Boyd Steven Kyle	Director	May 14 '26	Buy	2.99	25,000	74,750	113,462	May 14 08:55 PM
Boyd Steven Kyle	Director	May 12 '26	Buy	2.98	25,000	74,500	63,462	May 14 08:55 PM
McGrath Kenneth J	Chief Financial Officer	Mar 20 '26	Buy	2.93	32,300	94,600	589,562	Mar 23 07:23 PM
EGLINTON MANNER CARRIE	President & CEO	Mar 20 '26	Buy	2.93	32,300	94,597	2,190,874	Mar 23 07:23 PM
McGrath Kenneth J	Chief Financial Officer	Mar 13 '26	Buy	3.00	22,021	66,030	557,262	Mar 16 08:01 PM
EGLINTON MANNER CARRIE	President & CEO	Mar 13 '26	Buy	3.00	22,022	66,033	2,158,574	Mar 16 08:01 PM
Mara Aspinall	Board	Dec 04 '25	Proposed Sale	2.51	89,716	225,000		Dec 04 01:45 PM
Gagliano Nancy J	Director	Nov 28 '25	Buy	2.37	2,100	4,982	160,254	Dec 02 04:16 PM

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offers oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in 2000 in and is headquartered in Bethlehem, PA.

PresidentMs. Carrie Eglinton Manner

Chief Financial OfficerMr. Kenneth J. McGrath

Senior VPMs. Michele Anthony

Diagnostics R&D & Chief TechnologistMs. Karen Davies

Sample Management Solutions R&D & Chief ScientistMr. Rafal Iwasiow Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Orasure Technologies Inc

Upgrade your Finviz experience